CD36 and breast carcinoma: While not as extensively studied, the fatty acid translocase encoding CD36 has been recently reported to be associated with the progression of liver cancer22, breast cancer33, glioblastoma34 and the in vitro proliferation of sarcoma and breast cancer cells35.